Active, Not Recruiting
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
NCT04017650
- Conditions
- BRAF NP_004324.2:p.V600E, Colonic Diseases, Colonic Neoplasms, +30 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States